Tag: Reduce it

According to clinical trial data, Vascepa can significantly lower triglyceride levels within just 12 weeks of treatment. This initial reduction is part of a broader, long-term therapeutic strategy, with continued benefits observed over years, including a reduction in cardiovascular risk.

According to the landmark REDUCE-IT clinical trial, icosapent ethyl reduced triglyceride levels by nearly 20% compared to placebo after one year in statin-treated patients with cardiovascular risk factors. The specific percentage reduction varies based on the patient's starting triglyceride level and other factors, but significant lowering is consistently observed across studies.